key: cord-0878264-uhuve3du
authors: Giraud-Gatineau, Audrey; Colson, Philippe; Jimeno, Marie-Thérèse; Zandotti, Christine; Ninove, Laetitia; Boschi, Céline; Lagier, Jean-Christophe; Scola, Bernard LA; Chaudet, Hervé; Raoult, Didier
title: Comparison of mortality associated with respiratory viral infections between December 2019 and March 2020 with that of the previous year, Southeastern France
date: 2020-05-07
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.05.001
sha: 6ad03cf6138bcbba24ccad6612a8003fb3c87196
doc_id: 878264
cord_uid: uhuve3du

Abstract Respiratory viruses are a major global cause of mortality worldwide and in France where they cause several thousands of deaths yearly. University Hospital Institute-Méditerranée Infection performs real-time surveillance of all diagnoses of infections and associated deaths in public hospitals of Marseille, Southeastern France. Here, mortality associated with diagnoses of respiratory viruses was compared during colder months of 2018-2019 and 2019-2020 (week 47-week 14). In 2018-2019, 73 patients (0.17% of 42,851 hospitalized patients) died after being diagnosed with a respiratory virus; 40 and 13 deaths occurred in patients diagnosed with influenza A virus and respiratory syncytial virus (RSV), respectively. In 2019-2020, 50 patients (0.10% of 49,043 patients hospitalized) died after being diagnosed with a common respiratory virus; 7 and 7 deaths occurred in patients diagnosed with influenza A virus and RSV, respectively. Additionally, 55 patients died after being diagnosed with SARS-CoV-2. The proportion of respiratory virus-associated deaths among hospitalized patients was thus significantly lower for common respiratory viruses in 2019-2020 than in 2018-2019 (102 versus 170 per 100,000 hospitalized patients; p=0.003), majoritarily as a consequence of a decrease in influenza A virus (-83%) and RSV (-46%)-associated deaths. Overall, the proportion of respiratory virus-associated deaths among hospitalized patients was higher but not significantly in 2019-2020 than in 2018-2019 (214 versus 170 per 100,000 hospitalized patients; p=0.08, Yates-corrected chi-square test). These findings allow putting into perspective the death burden of SARS-CoV-2 infections in our geographical area.

). Additionally, we tested since the 29 th of January 25,786 patients for 87 SARS-CoV-2 using a reverse transcription-PCR assay ( Periods of time analysed in the present study are indicated by rectangle with a grey background. 180 

Estimates of the global, regional, and national morbidity, 152 mortality, and aetiologies of lower respiratory tract infections in 195 countries: a 153 systematic analysis for the Global Burden of Disease Study

Rapid viral 159 diagnosis and ambulatory management of suspected COVID-19 cases presenting at the 160 infectious diseases referral hospital

Mortality burden of 163 the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the 164 A/H3N2 pandemic

Global mortality 166 associated with seasonal influenza epidemics: New burden estimates and predictors from 167 the GLaMOR Project

Characteristics of hospitalizations with an influenza 169 diagnosis

CoV-2: fear versus data

 Less common respiratory virus-associated deaths at hospital in

 Majoritarily due to decreases of influenza A virus and RSV-associated deaths 193  55 deaths were associated with a SARS-CoV-2 diagnosis

 Similar respiratory virus-associated mortality among hospitalized patients

 Limited impact of SARS-CoV-2 infections on number of deaths of any cause among hospitalized people